Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
4,901 trials
HIV-1 Infection · HIV Infections
Primary: Plasma Area Under Curve (AUC 0-12 hr ) for Raltegravir — 12.36; 17.95; 17.12 µM*hr
Healthy
Primary: Maximum Plasma Concentration (Cmax) of Guanfacine — 2.6; 2.7 ng/ml
Healthy
Primary: Cmax — 2.8358; 2.9768 µg/mL
Healthy
Primary: Area Under the Serum Concentration-time Curve (AUC 0-48) for Exogenous Calcitriol — 111; -181 pg*h/ml — p=0.171
Healthy
Primary: Cmax - Maximum Observed Plasma Concentration — 78.4; 78.2 ng/mL
Healthy
Primary: Cmax - Maximum Observed Plasma Concentration — 85.1; 83.0 ng/mL
Healthy
Primary: Cmax - Maximum Observed Plasma Concentration — 9.81; 9.58 ng/mL
Healthy
Primary: Cmax - Maximum Observed Plasma Concentration — 109; 97.6 ng/mL
Healthy
Primary: Number of Study Participants Who Tolerated ST-246 (250, 400 or 800mg) as Determined by Changes in Safety Parameters, According to the Division of Acquired…
Postmenopausal Symptoms
Primary: Immunohistochemistry (IHC) Proliferative Effects Measurement — 0.73; 0.43; 0.25 Square root of % positive stained cells — p=<0.001
Healthy Volunteers
Primary: Cmax - Maximum Observed Plasma Concentration — 62.0; 61.5 ng/mL
Healthy Volunteers
Primary: Cmax - Maximum Observed Plasma Concentration — 9.60; 9.38 ng/mL
Healthy Volunteers
Primary: Cmax - Maximum Observed Plasma Concentration — 14.2; 13.6 ng/mL
Healthy
Primary: Cmax - Maximum Observed Plasma Concentration — 47.4; 48.4 ng/mL
Allergic Rhinitis
Primary: Fold Change From Baseline at Hour 8 in Interleukin 5 (IL-5) Concentration — 26.94; 6.70; 1.86 Fold Change — p=0.002